KD
Krista Davis
SVP, Chief Hr Officer

Krista Davis insider trades: Ani Pharmaceuticals (ANIP) stock sales

SVP, Chief Hr Officer, Ani Pharmaceuticals Last trade Mar 9, 2026 21 Form 4 filings
$919K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Krista reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 9, 2026ANIP↓ Sell$488K
Feb 20, 2026ANIP↓ Sell$296K
Dec 18, 2025ANIP↓ Sell$134K
Sep 19, 2025ANIP↓ Sell$98K
Aug 22, 2025ANIP↓ Sell$161K
Mar 19, 2025ANIP↓ Sell$121K
Mar 7, 2025ANIP↓ Sell$61K
Feb 21, 2025ANIP↓ Sell$60K
Dec 11, 2024ANIP↓ Sell$60K
Nov 15, 2023ANIP↓ Sell$141K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Krista Davis's insider trades

Krista Davis is SVP, Chief Hr Officer at Ani Pharmaceuticals (ANIP). Since Nov 15, 2023, Krista has reported no open-market purchases and 10 sales worth $1.6M on SEC Form 4. In the last 12 months: 3 sales ($919K).

Their filings also include shares withheld for taxes (8 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.